Evidence map›Paper›PMID 34004601›Full record

ArticleRespiration; international review of thoracic diseases

Postdischarge Recovery after Acute Pediatric Lung Disease Can Be Quantified with Digital Biomarkers.

Matthijs D Kruizinga, Allison Moll, Ahnjili Zhuparris, Dimitrios Ziagkos, Frederik E Stuurman, Marianne Nuijsink, Adam F Cohen, Gertjan J A Driessen

Abstract read
In one paragraph

Article in Respiration; international review of thoracic diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Patient-reported outcome measures for paediatric acute lower respiratory infection studies.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Matthijs D KruizingaCentre for Human Drug Research, Leiden, The Netherlands.
Allison MollCentre for Human Drug Research, Leiden, The Netherlands.
Ahnjili ZhuparrisCentre for Human Drug Research, Leiden, The Netherlands.
Dimitrios ZiagkosCentre for Human Drug Research, Leiden, The Netherlands.
Frederik E StuurmanCentre for Human Drug Research, Leiden, The Netherlands.
Marianne NuijsinkJuliana Children's Hospital, HAGA Teaching Hospital, The Hague, The Netherlands.
Adam F CohenCentre for Human Drug Research, Leiden, The Netherlands.
Gertjan J A DriessenJuliana Children's Hospital, HAGA Teaching Hospital, The Hague, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric patients admitted for acute lung disease are treated and monitored in the hospital, after which full recovery is achieved at home. Many studies report in-hospital recovery, but little is known regarding the time to full recovery after hospital discharge. Technological innovations have led to increased interest in home-monitoring and digital biomarkers. The aim of this study was to describe at-home recovery of 3 common pediatric respiratory diseases using a questionnaire and wearable device.

methodsIn this study, patients admitted due to pneumonia (n = 30), preschool wheezing (n = 30), and asthma exacerbation (AE; n = 11) were included. Patients were monitored with a smartwatch and a questionnaire during admission, with a 14-day recovery period and a 10-day "healthy" period. Median compliance was calculated, and a mixed-effects model was fitted for physical activity and heart rate (HR) to describe the recovery period, and the physical activity recovery trajectory was correlated to respiratory symptom scores.

resultsMedian compliance was 47% (interquartile range [IQR] 33-81%) during the entire study period, 68% (IQR 54-91%) during the recovery period, and 28% (IQR 0-74%) during the healthy period. Patients with pneumonia reached normal physical activity 12 days postdischarge, while subjects with wheezing and AE reached this level after 5 and 6 days, respectively. Estimated mean physical activity was closely correlated with the estimated mean symptom score. HR measured by the smartwatch showed a similar recovery trajectory for subjects with wheezing and asthma, but not for subjects with pneumonia.

conclusionsThe digital biomarkers, physical activity, and HR obtained via smartwatch show promise for quantifying postdischarge recovery in a noninvasive manner, which can be useful in pediatric clinical trials and clinical care.

Indexed as

AsthmaPneumoniaAcute DiseaseAftercareBiomarkersChildChild, PreschoolHumansPatient DischargeRespiratory SoundsBiomarkersAcute lung diseaseAsthmaAt-home recoveryLinear mixed modelPediatricsPneumoniaWearableWheezing

Identifiers

PMID34004601
PMCPMC8619741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.